(NICE) Nice - Overview
Sector: TechnologyIndustry: Software - Application | Exchange NASDAQ (USA) | Currency USD | Market Cap: 7.117m | Total Return -31.2% in 12m
Stock: Cloud Platforms, Customer Engagement, Financial Crime, AI
Total Rating 58
Risk 89
Buy Signal -0.97
| Risk 5d forecast | |
|---|---|
| Volatility | 41.8% |
| Relative Tail Risk | -9.78% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.76 |
| Alpha | -47.81 |
| Character TTM | |
|---|---|
| Beta | 1.354 |
| Beta Downside | 0.894 |
| Drawdowns 3y | |
|---|---|
| Max DD | 63.56% |
| CAGR/Max DD | -0.34 |
EPS (Earnings per Share)
Revenue
Risks
Technicals:
choppy
Description: NICE Nice March 04, 2026
NICE Ltd. (NASDAQ: NICE) provides AI-powered cloud platforms. These platforms focus on customer engagement, financial crime prevention, and compliance.
The companys offerings include CXone Mpower for customer service automation, and NICE Evidencentral for digital evidence management in criminal justice. NICE also offers X-Sight and Xceed, which are AI cloud platforms targeting anti-money laundering and fraud prevention for different market segments. The business model is primarily software-as-a-service (SaaS) leveraging artificial intelligence.
NICEs data intelligence solutions help organizations convert raw data into actionable insights to detect and prevent financial crimes. The financial crime and compliance sector is experiencing increased regulatory scrutiny and digital transformation. Further research on ValueRay can provide deeper insights into NICEs market position and financial performance.
Headlines to watch out for
- Cloud platform adoption drives Customer Engagement segment growth
- AI-powered financial crime solutions increase enterprise demand
- Regulatory changes impact Financial Crime and Compliance segment revenue
- Competition in CX and compliance software affects market share
Piotroski VR‑10 (Strict, 0-10) 8.0
| Net Income: 613.0m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.13 > 0.02 and ΔFCF/TA -0.82 > 1.0 |
| NWC/Revenue: 16.66% < 20% (prev 37.67%; Δ -21.01% < -1%) |
| CFO/TA 0.14 > 3% & CFO 718.4m > Net Income 613.0m |
| Net Debt (-218.1m) to EBITDA (861.5m): -0.25 < 3 |
| Current Ratio: 1.55 > 1.5 & < 3 |
| Outstanding Shares: last quarter (62.6m) vs 12m ago -3.44% < -2% |
| Gross Margin: 66.41% > 18% (prev 0.67%; Δ 6.57k% > 0.5%) |
| Asset Turnover: 56.73% > 50% (prev 51.65%; Δ 5.08% > 0%) |
| Interest Coverage Ratio: -15.35 > 6 (EBITDA TTM 861.5m / Interest Expense TTM -43.1m) |
Altman Z'' 6.43
| A: 0.10 (Total Current Assets 1.38b - Total Current Liabilities 887.6m) / Total Assets 5.11b |
| B: 0.65 (Retained Earnings 3.31b / Total Assets 5.11b) |
| C: 0.13 (EBIT TTM 662.0m / Avg Total Assets 5.20b) |
| D: 2.70 (Book Value of Equity 3.31b / Total Liabilities 1.23b) |
| Altman-Z'' Score: 6.43 = AAA |
Beneish M -2.69
| DSRI: 1.06 (Receivables 737.9m/648.2m, Revenue 2.95b/2.74b) |
| GMI: 1.01 (GM 66.41% / 66.75%) |
| AQI: 1.43 (AQ_t 0.68 / AQ_t-1 0.47) |
| SGI: 1.08 (Revenue 2.95b / 2.74b) |
| TATA: -0.02 (NI 613.0m - CFO 718.4m) / TA 5.11b) |
| Beneish M-Score: -2.69 (Cap -4..+1) = A |
What is the price of NICE shares?
As of March 28, 2026, the stock is trading at USD 109.41 with a total of 465,124 shares traded.
Over the past week, the price has changed by -8.37%, over one month by -5.60%, over three months by -2.91% and over the past year by -31.21%.
Over the past week, the price has changed by -8.37%, over one month by -5.60%, over three months by -2.91% and over the past year by -31.21%.
Is NICE a buy, sell or hold?
Nice has received a consensus analysts rating of 4.33.
Therefore, it is recommended to buy NICE.
- StrongBuy: 10
- Buy: 4
- Hold: 4
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the NICE price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 154.3 | 41% |
| Analysts Target Price | 154.3 | 41% |
NICE Fundamental Data Overview March 25, 2026
P/E Trailing = 12.1003
P/E Forward = 10.8108
P/S = 2.4163
P/B = 1.8137
P/EG = 0.9917
Revenue TTM = 2.95b USD
EBIT TTM = 662.0m USD
EBITDA TTM = 861.5m USD
Long Term Debt = 88.8m USD (from capitalLeaseObligations, last quarter)
Short Term Debt = 13.7m USD (from shortTermDebt, last quarter)
Debt = 163.9m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -218.1m USD (from netDebt column, last quarter)
Enterprise Value = 6.86b USD (7.12b + Debt 163.9m - CCE 420.0m)
Interest Coverage Ratio = -15.35 (Ebit TTM 662.0m / Interest Expense TTM -43.1m)
EV/FCF = 10.32x (Enterprise Value 6.86b / FCF TTM 664.5m)
FCF Yield = 9.69% (FCF TTM 664.5m / Enterprise Value 6.86b)
FCF Margin = 22.52% (FCF TTM 664.5m / Revenue TTM 2.95b)
Net Margin = 20.78% (Net Income TTM 613.0m / Revenue TTM 2.95b)
Gross Margin = 66.41% ((Revenue TTM 2.95b - Cost of Revenue TTM 991.0m) / Revenue TTM)
Gross Margin QoQ = 65.33% (prev 66.81%)
Tobins Q-Ratio = 1.34 (Enterprise Value 6.86b / Total Assets 5.11b)
Interest Expense / Debt = 3.73% (Interest Expense 6.11m / Debt 163.9m)
Taxrate = 17.58% (32.3m / 183.8m)
NOPAT = 545.6m (EBIT 662.0m * (1 - 17.58%))
Current Ratio = 1.55 (Total Current Assets 1.38b / Total Current Liabilities 887.6m)
Debt / Equity = 0.04 (Debt 163.9m / totalStockholderEquity, last quarter 3.88b)
Debt / EBITDA = -0.25 (Net Debt -218.1m / EBITDA 861.5m)
Debt / FCF = -0.33 (Net Debt -218.1m / FCF TTM 664.5m)
Total Stockholder Equity = 3.74b (last 4 quarters mean from totalStockholderEquity)
RoA = 11.79% (Net Income 613.0m / Total Assets 5.11b)
RoE = 16.38% (Net Income TTM 613.0m / Total Stockholder Equity 3.74b)
RoCE = 17.28% (EBIT 662.0m / Capital Employed (Equity 3.74b + L.T.Debt 88.8m))
RoIC = 13.74% (NOPAT 545.6m / Invested Capital 3.97b)
WACC = 10.58% (E(7.12b)/V(7.28b) * Re(10.75%) + D(163.9m)/V(7.28b) * Rd(3.73%) * (1-Tc(0.18)))
Discount Rate = 10.75% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -2.44%
[DCF] Terminal Value 73.65% ; FCFF base≈691.9m ; Y1≈853.5m ; Y5≈1.46b
[DCF] Fair Price = 277.3 (EV 16.26b - Net Debt -218.1m = Equity 16.48b / Shares 59.4m; r=10.58% [WACC]; 5y FCF grow 25.0% → 3.0% )
EPS Correlation: 98.43 | EPS CAGR: 16.97% | SUE: 0.46 | # QB: 0
Revenue Correlation: 98.90 | Revenue CAGR: 11.43% | SUE: 4.0 | # QB: 1
EPS next Quarter (2026-06-30): EPS=2.63 | Chg7d=-0.029 | Chg30d=-0.036 | Revisions Net=-6 | Analysts=16
EPS current Year (2026-12-31): EPS=10.95 | Chg7d=-0.005 | Chg30d=-0.001 | Revisions Net=-3 | Growth EPS=-11.0% | Growth Revenue=+8.1%
EPS next Year (2027-12-31): EPS=12.44 | Chg7d=-0.039 | Chg30d=-0.025 | Revisions Net=+5 | Growth EPS=+13.6% | Growth Revenue=+10.0%
[Analyst] Revisions Ratio: -0.43 (4 Up / 10 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 2.5% (Discount Rate 10.8% - Earnings Yield 8.3%)
[Growth] Growth Spread = +4.5% (Analyst 7.0% - Implied 2.5%)
P/E Forward = 10.8108
P/S = 2.4163
P/B = 1.8137
P/EG = 0.9917
Revenue TTM = 2.95b USD
EBIT TTM = 662.0m USD
EBITDA TTM = 861.5m USD
Long Term Debt = 88.8m USD (from capitalLeaseObligations, last quarter)
Short Term Debt = 13.7m USD (from shortTermDebt, last quarter)
Debt = 163.9m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -218.1m USD (from netDebt column, last quarter)
Enterprise Value = 6.86b USD (7.12b + Debt 163.9m - CCE 420.0m)
Interest Coverage Ratio = -15.35 (Ebit TTM 662.0m / Interest Expense TTM -43.1m)
EV/FCF = 10.32x (Enterprise Value 6.86b / FCF TTM 664.5m)
FCF Yield = 9.69% (FCF TTM 664.5m / Enterprise Value 6.86b)
FCF Margin = 22.52% (FCF TTM 664.5m / Revenue TTM 2.95b)
Net Margin = 20.78% (Net Income TTM 613.0m / Revenue TTM 2.95b)
Gross Margin = 66.41% ((Revenue TTM 2.95b - Cost of Revenue TTM 991.0m) / Revenue TTM)
Gross Margin QoQ = 65.33% (prev 66.81%)
Tobins Q-Ratio = 1.34 (Enterprise Value 6.86b / Total Assets 5.11b)
Interest Expense / Debt = 3.73% (Interest Expense 6.11m / Debt 163.9m)
Taxrate = 17.58% (32.3m / 183.8m)
NOPAT = 545.6m (EBIT 662.0m * (1 - 17.58%))
Current Ratio = 1.55 (Total Current Assets 1.38b / Total Current Liabilities 887.6m)
Debt / Equity = 0.04 (Debt 163.9m / totalStockholderEquity, last quarter 3.88b)
Debt / EBITDA = -0.25 (Net Debt -218.1m / EBITDA 861.5m)
Debt / FCF = -0.33 (Net Debt -218.1m / FCF TTM 664.5m)
Total Stockholder Equity = 3.74b (last 4 quarters mean from totalStockholderEquity)
RoA = 11.79% (Net Income 613.0m / Total Assets 5.11b)
RoE = 16.38% (Net Income TTM 613.0m / Total Stockholder Equity 3.74b)
RoCE = 17.28% (EBIT 662.0m / Capital Employed (Equity 3.74b + L.T.Debt 88.8m))
RoIC = 13.74% (NOPAT 545.6m / Invested Capital 3.97b)
WACC = 10.58% (E(7.12b)/V(7.28b) * Re(10.75%) + D(163.9m)/V(7.28b) * Rd(3.73%) * (1-Tc(0.18)))
Discount Rate = 10.75% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -2.44%
[DCF] Terminal Value 73.65% ; FCFF base≈691.9m ; Y1≈853.5m ; Y5≈1.46b
[DCF] Fair Price = 277.3 (EV 16.26b - Net Debt -218.1m = Equity 16.48b / Shares 59.4m; r=10.58% [WACC]; 5y FCF grow 25.0% → 3.0% )
EPS Correlation: 98.43 | EPS CAGR: 16.97% | SUE: 0.46 | # QB: 0
Revenue Correlation: 98.90 | Revenue CAGR: 11.43% | SUE: 4.0 | # QB: 1
EPS next Quarter (2026-06-30): EPS=2.63 | Chg7d=-0.029 | Chg30d=-0.036 | Revisions Net=-6 | Analysts=16
EPS current Year (2026-12-31): EPS=10.95 | Chg7d=-0.005 | Chg30d=-0.001 | Revisions Net=-3 | Growth EPS=-11.0% | Growth Revenue=+8.1%
EPS next Year (2027-12-31): EPS=12.44 | Chg7d=-0.039 | Chg30d=-0.025 | Revisions Net=+5 | Growth EPS=+13.6% | Growth Revenue=+10.0%
[Analyst] Revisions Ratio: -0.43 (4 Up / 10 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 2.5% (Discount Rate 10.8% - Earnings Yield 8.3%)
[Growth] Growth Spread = +4.5% (Analyst 7.0% - Implied 2.5%)